Leading the Standardization of Non-Invasive Liver Disease Diagnostics

Severance Hospital announced on the 9th that it had recently been designated as a "FibroScan Center of Excellence (FibroScan Regional Hub Center)" by the global liver disease diagnostics company Echosens, and held a plaque unveiling ceremony on the 6th of this month. With this designation, Severance Hospital will serve as a key regional hub that integrates clinical practice, research, and education in the field of non-invasive liver disease diagnostics.


Kim Seungeop, professor of gastroenterology at Severance Hospital (photo right), and Fong Grace, Head of Asia-Pacific at Ecosense (photo left), are taking a commemorative photo at the plaque unveiling ceremony. Yonsei University Health System

Kim Seungeop, professor of gastroenterology at Severance Hospital (photo right), and Fong Grace, Head of Asia-Pacific at Ecosense (photo left), are taking a commemorative photo at the plaque unveiling ceremony. Yonsei University Health System

View original image

Echosens, which has FibroScan technology for the non-invasive assessment of liver fibrosis and fatty liver, has built a broad network of medical institutions and research partners around the world. Among these, Regional Hub Centers are designated for institutions that play a central role in the clinical application of this technology, data accumulation, education, and research collaboration.


Severance Hospital was selected as a hub center based on its accumulated clinical experience in treating patients with various liver diseases, including chronic liver disease, metabolic dysfunction-associated steatotic liver disease, and viral hepatitis, as well as its systematic testing and research infrastructure. Going forward, the hospital plans to contribute to the early diagnosis of liver diseases and the improvement of care quality through initiatives such as: (1) standardization of non-invasive liver disease diagnostics, (2) accumulation of clinical data and research collaboration, and (3) operation of educational programs for local healthcare professionals.


In particular, building on the academic and educational collaboration agreement signed last year with Echosens to promote liver health in the Asia-Pacific (APAC) region, the hospital plans to expand liver disease management capabilities and training opportunities not only in Korea but also across Asia.



Kim Seungeop, Head of the FibroScan Regional Hub Center, said, "This designation as a Regional Hub Center is an international recognition of Severance Hospital's accumulated capabilities in liver disease diagnostics and research," adding, "We will work to firmly establish a non-invasive diagnostic system that minimizes the burden on patients in clinical practice, and to spread standardized care through collaboration with local medical institutions."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing